Stock listing
Frankfurt:P0F Egetis Therapeutics AB Aktie
German listing (Frankfurt) of Egetis Therapeutics AB · home listing Stockholm:EGTX
Follow Egetis Therapeutics AB into a list and get an email when it puts out news.
Share price · FWB:P0F
€0.96 EUR -0.01 (-0.8%)
Close on Nov 20, 2026
- Day range
- €0.96 – €0.964 EURNov 20, 2026
- Market cap
- €446.4M EURAt the close on Nov 20, 2026 · price × 465.0M shares outstanding
- 52-week range
- €0.36 – €1.01 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- €2,204 EURMedian day 0 shares · 47 days with no trades · last 3 months, Aug 20, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Stockholm:EGTX · Home | 11.12 SEK | -0.02 (-0.2%) | 1,812,099 | 11.12 | 11.14 | 11.12 | 11.14 | Close on Nov 20, 2026 |
| LSE:0ABW | 11.14 SEK | +0.01 (+0.1%) | 255,262 | 11.14 | 11.15 | 11.13 | 11.13 | Close on Nov 20, 2026 |
| Frankfurt:P0F | €0.96 EUR | -0.008 (-0.8%) | — | €0.964 | €0.964 | €0.96 | €0.968 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 6, 2026 · FWB:P0F · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €0.988 | +0.067 | +7.3% | €0.988 | €0.997 | €0.975 | 0 | |
| €0.921 | +0.04 | +4.5% | €0.945 | €1.011 | €0.914 | 0 | |
| €0.881 | +0.004 | +0.5% | €0.877 | €0.883 | €0.877 | 0 | |
| €0.877 | -0.002 | -0.2% | €0.877 | €0.877 | €0.877 | 0 | |
| €0.879 | -0.014 | -1.6% | €0.88 | €0.891 | €0.876 | 0 | |
| €0.893 | -0.01 | -1.1% | €0.903 | €0.909 | €0.886 | 2,120 | |
| €0.903 | +0.049 | +5.7% | €0.906 | €0.907 | €0.903 | 0 | |
| €0.854 | +0.012 | +1.4% | €0.854 | €0.854 | €0.854 | 2,860 | |
| €0.842 | +0.042 | +5.2% | €0.80 | €0.842 | €0.795 | 0 | |
| €0.80 | +0.002 | +0.3% | €0.782 | €0.804 | €0.779 | 0 | |
| €0.798 | -0.029 | -3.5% | €0.798 | €0.798 | €0.798 | 0 | |
| €0.827 | +0.032 | +4.0% | €0.827 | €0.827 | €0.827 | 0 | |
| €0.795 | +0.002 | +0.3% | €0.795 | €0.795 | €0.795 | 0 | |
| €0.793 | -0.007 | -0.9% | €0.789 | €0.795 | €0.788 | 0 | |
| €0.80 | +0.004 | +0.5% | €0.80 | €0.80 | €0.80 | 0 | |
| €0.796 | -0.017 | -2.1% | €0.796 | €0.796 | €0.796 | 0 | |
| €0.813 | -0.021 | -2.5% | €0.813 | €0.813 | €0.813 | 0 | |
| €0.834 | -0.037 | -4.2% | €0.834 | €0.834 | €0.834 | 0 | |
| €0.871 | +0.02 | +2.4% | €0.866 | €0.873 | €0.865 | 0 | |
| €0.851 | -0.001 | -0.1% | €0.851 | €0.851 | €0.851 | 2,000 | |
| €0.852 | +0.029 | +3.5% | €0.849 | €0.908 | €0.845 | 2,000 | |
| €0.823 | +0.007 | +0.9% | €0.823 | €0.823 | €0.823 | 0 | |
| €0.816 | +0.039 | +5.0% | €0.818 | €0.819 | €0.813 | 0 | |
| €0.777 | -0.001 | -0.1% | €0.777 | €0.777 | €0.777 | 0 | |
| €0.778 | -0.004 | -0.5% | €0.778 | €0.778 | €0.778 | 0 | |
| €0.782 | -0.014 | -1.8% | €0.798 | €0.807 | €0.775 | 0 | |
| €0.796 | -0.006 | -0.7% | €0.756 | €0.797 | €0.756 | 0 | |
| €0.802 | +0.101 | +14.4% | €0.719 | €0.804 | €0.718 | 50 | |
| €0.701 | +0.079 | +12.7% | €0.701 | €0.701 | €0.701 | 0 | |
| €0.622 | -0.038 | -5.8% | €0.66 | €0.693 | €0.621 | 1,048 | |
| €0.66 | +0.005 | +0.8% | €0.654 | €0.661 | €0.653 | 18,000 | |
| €0.655 | -0.018 | -2.7% | €0.655 | €0.655 | €0.655 | 0 | |
| €0.673 | -0.003 | -0.4% | €0.673 | €0.673 | €0.669 | 0 | |
| €0.676 | +0.007 | +1.0% | €0.647 | €0.678 | €0.639 | 0 | |
| €0.669 | -0.009 | -1.3% | €0.669 | €0.669 | €0.669 | 0 | |
| €0.678 | +0.01 | +1.5% | €0.678 | €0.678 | €0.678 | 0 | |
| €0.668 | +0.005 | +0.8% | €0.668 | €0.668 | €0.668 | 0 | |
| €0.663 | -0.012 | -1.8% | €0.663 | €0.663 | €0.663 | 0 | |
| €0.675 | +0.006 | +0.9% | €0.675 | €0.675 | €0.675 | 0 | |
| €0.669 | -0.012 | -1.8% | €0.669 | €0.669 | €0.669 | 0 | |
| €0.681 | -0.008 | -1.2% | €0.681 | €0.681 | €0.681 | 0 | |
| €0.689 | 0.00 | 0.0% | €0.689 | €0.689 | €0.689 | 0 | |
| €0.689 | -0.04 | -5.5% | €0.694 | €0.698 | €0.685 | 0 | |
| €0.729 | +0.025 | +3.6% | €0.671 | €0.729 | €0.67 | 3,000 | |
| €0.704 | -0.006 | -0.8% | €0.656 | €0.715 | €0.656 | 270 | |
| €0.71 | +0.045 | +6.8% | €0.681 | €0.711 | €0.671 | 145,000 | |
| €0.665 | -0.013 | -1.9% | €0.665 | €0.665 | €0.665 | 0 | |
| €0.678 | +0.006 | +0.9% | €0.678 | €0.678 | €0.678 | 0 | |
| €0.672 | -0.012 | -1.8% | €0.672 | €0.672 | €0.672 | 0 | |
| €0.684 | -0.008 | -1.2% | €0.684 | €0.684 | €0.684 | 0 | |
| €0.692 | +0.006 | +0.9% | €0.692 | €0.692 | €0.692 | 0 | |
| €0.686 | +0.003 | +0.4% | €0.686 | €0.686 | €0.686 | 0 | |
| €0.683 | +0.037 | +5.7% | €0.683 | €0.683 | €0.683 | 0 | |
| €0.646 | +0.014 | +2.2% | €0.646 | €0.646 | €0.646 | 0 | |
| €0.632 | +0.047 | +8.0% | €0.632 | €0.632 | €0.632 | 0 | |
| €0.585 | -0.012 | -2.0% | €0.585 | €0.585 | €0.585 | 0 | |
| €0.597 | -0.005 | -0.8% | €0.597 | €0.597 | €0.597 | 0 |
- Ticker
- Frankfurt:P0F
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Sep 29, 2026
Egetis Therapeutics Announces U.S. FDA Approval of EMCITATE(R) (tiratricol) for Patients with MCT8 Deficiency
Latest earnings call · Aug 21, 2026
Egetis Therapeutics (Stockholm:EGTX) Q2 2026 Earnings Call
Replay and transcript
Latest deck · October 2026
Investor Presentation (October 2026)
Investor deck · 62 slides
Calls
Replays
Egetis Therapeutics (Stockholm:EGTX) Q2 2026 Earnings Call
Fri, Aug 21, 2026 · 8:00 AM ET
Watch TranscriptEgetis Therapeutics (Stockholm:EGTX) Q1 2026 Earnings Call
Wed, Apr 29, 2026 · 4:00 AM ET
Watch Transcript
Latest news
Egetis Therapeutics Announces U.S. FDA Approval of EMCITATE(R) (tiratricol) for Patients with MCT8 Deficiency
Sep 29, 2026
Closed €0.701 (+12.7%) on Sep 29, 2026
Egetis Therapeutics Announces U.S. FDA Approval of EMCITATE® (tiratricol) for Patients with MCT8 Deficiency
Sep 28, 2026
Closed €0.701 (+12.7%) on Sep 29, 2026
Egetis Therapeutics to Participate in Upcoming Investor Conferences in September
Sep 3, 2026
Closed €0.665 (-1.9%) on Sep 3, 2026
Egetis' Interim report Q2 2026
Aug 21, 2026
Closed €0.585 (-2.0%) on Aug 21, 2026
Invitation to Presentation of Egetis’ Q2 2026 Report on August 21, 2026
Aug 7, 2026
Closed €0.596 (+1.4%) on Aug 7, 2026
Change in the number of shares and votes in Egetis Therapeutics
May 29, 2026
Closed €0.528 (+1.3%) on May 29, 2026
Exercise of options under employee stock option program and notification of insider trading
May 13, 2026
Closed €0.584 (+0.5%) on May 14, 2026
Egetis Announces Grant of Patent for MCT8 Deficiency Composition in The U.S.
May 5, 2026
Closed €0.526 (+8.0%) on May 5, 2026
Interim ReportQ12026
May 3, 2026
Closed €0.487 (-2.8%) on May 4, 2026
Invitation to Presentation of Egetis’ First Quarter 2026 Report on April 29, 2026
Apr 24, 2026
Closed €0.514 (-1.3%) on Apr 24, 2026
Financings
Private placement of new ordinary shares
Apr 21, 2026 · US$38.2M
Closed: SEK 350M raised · SEK 5.25 a share · Stifel +2
Dealers: Stifel (lead), Van Lanschot Kempen (co-lead), DNB Carnegie (co-lead)
Buyers: Frazier Life Sciences (expected to anchor the Directed Issue); Invus; Woodline Partners; Parkman Healthcare Partners; Linc AB; The Fourth Swedish National Pension Fund; Cidro Förvaltning AB (Peter Lindell); Unionen
Use of proceeds: Preparing Emcitate U.S. commercialization, RTH-beta indication expansion, working capital and general corporate purposes
Decks
Investor Presentation (October 2026)
Investor deck · 62 slides · October 2026
Q2 2026 Earnings Presentation
Earnings · 13 slides · Aug 21, 2026
Investor Presentation (August 2026)
Investor deck · 102 slides · August 2026
Investor Presentation (March 2026)
Investor deck · 101 slides · March 2026
Egetis Therapeutics AB on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 18 in the last 12 months · 18 in all · newest Sep 29, 2026 · oldest 2026
- Calls
- 2 calls with a replay · 2 with a transcript · latest Aug 21, 2026
- Decks
- 37 decks · latest October 2026
Where Egetis Therapeutics AB is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Stockholm:EGTX · Home listing | Stockholm | Sweden | SEK |
| LSE:0ABW | LSE | United Kingdom | SEK |
| OTC:PDPHF | OTC | United States | USD |
| Lang & Schwarz:A1JH3B | Lang & Schwarz | Germany | EUR |
| LS Exchange:A1JH3B | LS Exchange | Germany | EUR |
| Frankfurt:P0F · This page | Frankfurt | Germany | EUR |
| Aquis:EGTXS | Aquis | United Kingdom | SEK |
| gettex:P0F | gettex | Germany | EUR |
| Aquis:EGTXS | Aquis | United Kingdom | SEK |
| Munich:P0F | Munich | Germany | EUR |
| Stuttgart:P0F | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Egetis Therapeutics AB.